Stock Markets

Daily coverage of equity markets, sectors, and major indices.

In-depth reporting on U.S. and global stock markets, including index performance, sector rotation, earnings reactions, volatility trends, and notable single-stock moves. Designed to help traders and investors understand what is driving price action across equities.

Articles

30,142 total articles

Truist Lays Out Contrasting Views on Off-Price Retail Leaders

Truist Lays Out Contrasting Views on Off-Price Retail Leaders

Truist published new coverage ratings on Monday for leading off-price apparel retailers, assigning Buy ratings to Ross Stores and The TJX Companies while initiating Burlington Stores with a Hold. The firm cited scale, execution and store expansion potential as drivers for Ross and TJX, and expressed caution around Burlington's customer mix and comp…

Tel Aviv Stocks Slip; TA-35 Falls 1.62% to One-Month Low

Tel Aviv Stocks Slip; TA-35 Falls 1.62% to One-Month Low

Israel's main equity gauge closed lower on Monday, with the TA-35 sliding 1.62% to a fresh one-month low. Technology, Oil & Gas and Insurance sectors were the primary drags. Individual movers included gains in NICE, Shufersal and Next Vision Stabilized Systems, while Nova, Tower Semiconductor and Kenon recorded steep declines. Oil futures rose and …

Goldman Flags Middle East Escalation, AI Valuations as Key Market Risks

Goldman Flags Middle East Escalation, AI Valuations as Key Market Risks

Goldman Sachs cautions that a re-escalation of conflict in the Middle East or a prolonged closure of the Strait of Hormuz constitutes "the most obvious downside threat" to markets, even as equities, emerging-market assets and AI-related stocks reach new cycle highs. The bank highlights compressed risk premia after an Iran ceasefire, elevated valuat…

Supreme Court Lets Biden-Era Medicare Drug Price Negotiation Stand as Pharma Appeals Rejected

Supreme Court Lets Biden-Era Medicare Drug Price Negotiation Stand as Pharma Appeals Rejected

The U.S. Supreme Court on Monday refused to take up appeals from six major pharmaceutical companies contesting a Medicare drug price negotiation program established under the Inflation Reduction Act of 2022. By declining review, the justices left intact lower court decisions that rejected the companies' constitutional and administrative law claims,…

Regeneron Stock Plummets After Melanoma Drug Misses Primary Endpoint

Regeneron Stock Plummets After Melanoma Drug Misses Primary Endpoint

Regeneron shares fell sharply after its experimental combination of fianlimab and cemiplimab failed to meet the main goal in a late-stage trial for advanced melanoma. The company faces mounting pipeline scrutiny following other recent clinical and regulatory setbacks, even as it pursues a separate head-to-head study and a new partnership with Parab…

Supreme Court Lets Stand $194 Million Fraud Award Against Eli Lilly

Supreme Court Lets Stand $194 Million Fraud Award Against Eli Lilly

The US Supreme Court declined to hear Eli Lilly's appeal of a $194 million judgment in a whistleblower suit accusing the drugmaker of understating revenues from wholesalers to reduce Medicaid rebate obligations. The company had sought to overturn the False Claims Act on constitutional grounds but the justices refused to take the case.

Ryanair Chief Warns Prolonged Iran Conflict Could Topple European Carriers

Ryanair Chief Warns Prolonged Iran Conflict Could Topple European Carriers

Ryanair CEO Michael O’Leary cautioned that an extended Iran war and ongoing restrictions in the Strait of Hormuz could force European airlines into collapse. He singled out Wizz Air and Air Baltic as particularly vulnerable, questioned the recoverability of government support, and said Ryanair would consider buying aircraft if carriers sell assets.

Barclays Identifies Top European Food and Household Stocks Best Positioned for Renewed Cost Pressure

Barclays Identifies Top European Food and Household Stocks Best Positioned for Renewed Cost Pressure

Barclays says select European food and household product companies are better placed than peers to navigate a renewed round of cost pressures that differ from the 2022-23 cycle. The bank singles out Unilever, L'Oréal, Haleon and Danone as companies where execution quality, portfolio positioning and brand strength are likely to separate winners from…

BofA Lifts 2026 S&P EPS Call; Defends Semiconductors Against 'Bubble' Claims

BofA Lifts 2026 S&P EPS Call; Defends Semiconductors Against 'Bubble' Claims

Bank of America has increased its 2026 S&P 500 earnings-per-share estimate to $335, signaling 22% year-over-year growth, while maintaining a guarded stance on the index overall. Analyst Savita Subramanian disputes the popular view that semiconductors are in a valuation bubble and software stocks are cheap, pointing to upgraded semiconductor earning…